When samples treated with LPS alone were compared to those incubated with LPS and melatonin there were significant decreases in IL-1β (p < 0.0001), and NLRP3 (p = 0.0001) in children with DS but not controls (Fig. 6a, b). This evidence concerns the gene NLRP3 and Dravet syndrome.